0001209191-23-037405.txt : 20230615 0001209191-23-037405.hdr.sgml : 20230615 20230615170010 ACCESSION NUMBER: 0001209191-23-037405 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230615 FILED AS OF DATE: 20230615 DATE AS OF CHANGE: 20230615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chin Mark CENTRAL INDEX KEY: 0001734389 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38503 FILM NUMBER: 231018218 MAIL ADDRESS: STREET 1: 20 BERKELEY SQUARE, MAYFAIR CITY: LONDON STATE: X0 ZIP: W1J 6EQ ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Iterum Therapeutics plc CENTRAL INDEX KEY: 0001659323 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: FITZWILLIAM COURT, 1ST FLOOR STREET 2: LEESON CLOSE CITY: DUBLIN 2 STATE: L2 ZIP: D02 YW24 BUSINESS PHONE: (872) 225-6077 MAIL ADDRESS: STREET 1: FITZWILLIAM COURT, 1ST FLOOR STREET 2: LEESON CLOSE CITY: DUBLIN 2 STATE: L2 ZIP: D02 YW24 FORMER COMPANY: FORMER CONFORMED NAME: Iterum Therapeutics Ltd DATE OF NAME CHANGE: 20151124 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-15 0 0001659323 Iterum Therapeutics plc ITRM 0001734389 Chin Mark C/O ITERUM THERAPEUTICS PLC FITZWILLIAM COURT, FL. 1, LEESON CLOSE DUBLIN 2 L2 IRELAND 1 0 0 0 0 Ordinary Shares 2023-06-15 4 M 0 15853 0.00 A 18306 D Restricted Share Units 2023-06-15 4 M 0 15853 0.00 D Ordinary Shares 15853 0 D Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs. On August 17, 2022 the Issuer effected a 1 for 15 reverse share split (the "Reverse Share Split"). The number of ordinary shares reported in this Form 4 have been adjusted to reflect the Reverse Share Split. On June 15, 2022, the reporting person was granted an award of 15,853 RSUs, which vested in full on June 15, 2023. /s/ Mark Chin 2023-06-15